[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635890":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":32,"centralContacts":36,"locations":42,"responsibleParty":111,"collaborators":113,"id":116,"slug":117,"hasResults":118,"nctId":119,"briefTitle":120,"officialTitle":121,"acronym":122,"eligibilityCriteria":123,"healthyVolunteers":118,"sex":124,"minAge":125,"maxAge":10,"enrollmentInfo":126,"targetDuration":10,"studyType":129,"phases":10,"briefSummary":130,"conditions":131,"keywords":136,"overallStatus":45,"whyStopped":10,"lastUpdateSubmitDate":138,"lastUpdatePostDateStruct":139,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":147},{"fullName":5,"class":6},"ReSport Clinic","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Patellar tendinopathy",null,"Patellar tendinopathy treated with PRP",[13],"Biological: Platelet rich plasma (PRP)",{"label":15,"type":10,"description":16,"interventionNames":17},"Achilles tendinopathy","Achilles tendinopathy treated with PRP",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Plantar fasciosis","Plantar fasciosis treated with PRP",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Chronic epycondylitis","Chronic epycondylitis treated with PRP",[13],[27],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":10},"BIOLOGICAL","Platelet rich plasma (PRP)","A minimal description of the standard PRP preparation and administration protocol will be included to document clinical variability and enable comparative analyses. Across all participating centers, the following variables will be systematically recorded:\n\nType of PRP used (leukocyte-rich vs. leukocyte-poor), with standardized coding\n\nPreparation method (single vs. double centrifugation), including specification of the device used\n\nInjected volume\n\nAnatomical site and administration technique (ultrasound-guided whenever feasible)\n\nNumber of treatment sessions and interval between sessions",[15,23,9,19],[33],{"name":34,"affiliation":5,"role":35},"Ferran Abat Gonzalez, MD PhD","PRINCIPAL_INVESTIGATOR",[37],{"name":38,"role":39,"phone":40,"phoneExt":10,"email":41},"Resport Clinic, MD PhD","CONTACT","+34 93 2778709","abat@resportclinic.com",[43,61,75,84,98],{"facility":44,"status":45,"city":46,"state":10,"zip":47,"country":48,"countryCode":49,"cosmosGeoPoint":50,"geoPoint":55,"contacts":56},"Instituto Médico Arriaza","RECRUITING","A Coruña","15009","Spain","ES",{"type":51,"coordinates":52},"Point",[53,54],-8.396,43.37135,{"lat":54,"lon":53},[57],{"name":58,"role":39,"phone":59,"phoneExt":10,"email":60},"Dr Rafael Arriaza, MD","+34 981 113 030","info@arriaza.es",{"facility":62,"status":45,"city":63,"state":10,"zip":64,"country":48,"countryCode":49,"cosmosGeoPoint":65,"geoPoint":69,"contacts":70},"Instituto Cugat","Barcelona","08023",{"type":51,"coordinates":66},[67,68],2.15899,41.38879,{"lat":68,"lon":67},[71],{"name":72,"role":39,"phone":73,"phoneExt":10,"email":74},"Dr Ramón Cugat, MD PhD","+34 938 34 64 50","info@institutocugat.com",{"facility":5,"status":45,"city":63,"state":10,"zip":76,"country":48,"countryCode":49,"cosmosGeoPoint":77,"geoPoint":79,"contacts":80},"08029",{"type":51,"coordinates":78},[67,68],{"lat":68,"lon":67},[81],{"name":82,"role":39,"phone":83,"phoneExt":10,"email":41},"Dr Ferran Abat, MD PhD","+34 932 77 87 09",{"facility":85,"status":45,"city":86,"state":10,"zip":87,"country":48,"countryCode":49,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Ripoll y dePrado Medical Group","Madrid","28010",{"type":51,"coordinates":89},[90,91],-3.70256,40.4165,{"lat":91,"lon":90},[94],{"name":95,"role":39,"phone":96,"phoneExt":10,"email":97},"Dra Patricia Núñez, MD","+34 91 457 78 02","madrid@ripollydeprado.com",{"facility":99,"status":45,"city":100,"state":10,"zip":101,"country":48,"countryCode":49,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Hospital MIKS","Vitoria-Gasteiz","01010",{"type":51,"coordinates":103},[104,105],-2.67268,42.84998,{"lat":105,"lon":104},[108],{"name":109,"role":39,"phone":10,"phoneExt":10,"email":110},"Dr Mikel Sanchez, MD PhD","pacientes@hospitalmiks.com",{"type":112,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[114],{"name":115,"class":6},"BioSmartData","100635890","evaluation-of-platelet-rich-plasma-prp-treatment-in-tendinopathies-100635890",false,"NCT07558564","Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies","Multicenter Real-World Evidence (RWE) Study: Evaluation of Platelet-Rich Plasma (PRP) Treatment in Tendinopathies","RWE-TDP-PRP","Inclusion Criteria:\n\n* Clinical and\u002For ultrasound diagnosis of chronic tendinopathy (duration \\>6 weeks)\n* Age \\>18 years\n* Provision of written informed consent\n* Willingness and ability to complete follow-up assessments for 12 months\n\nExclusion Criteria:\n\n* Surgical treatment of the affected tendon within the previous 6 months\n* Corticosteroid injection within the last month\n* Systemic inflammatory disease (e.g., rheumatoid arthritis)\n* Coagulopathies or ongoing anticoagulant therapy\n* Complete blood count showing a platelet concentration \\\u003C100 × 10⁹\u002FL (to exclude patients with potential thrombocytopenia)\n* Pregnancy or breastfeeding","ALL","18 Years",{"count":127,"type":128},2000,"ESTIMATED","OBSERVATIONAL","This multicenter, prospective, observational study, based on real-world evidence (RWE), aims to evaluate the efficacy and safety of Platelet-Rich Plasma (PRP) treatment across four types of tendinopathies: patellar, Achilles, epicondylar, and plantar fasciosis. Data collection and analysis will be conducted using the BioSmartData® platform, including hematology analyzers for PRP characterization, clinical variables, treatment protocols, and longitudinal assessment of therapeutic response.",[132,133,134,135],"Patellar Tendinopathy","Achilles Tendinopathy (AT)","Epicondylitis, Lateral","Plantar Fasciitis, Chronic",[137],"tendinopathy, Real World Evidence (RWE), platelet-rich plasma, plantar fasciosis, epicondylitis, patellar tendon, Achilles tendon","2026-04-23",{"date":140,"type":141},"2026-04-30","ACTUAL",{"date":143,"type":128},"2026-04",{"date":145,"type":128},"2028-03",{"name":5,"class":6},5]